FDA Inspection
Recipharm Leganes SLURecipharm Leganes SLU – FDA Inspection, Jan 31, 2014
Record Details
This FDA Inspection record concerns Recipharm Leganes SLU, with an inspection on January 31, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Recipharm Leganes SLU
- Inspection Date
- January 31, 2014
- Product Type
- Drugs
View Company Profile
ID · b28cef23-09db-41b7-b8e1-165b25162101
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 868277
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Recipharm Leganes SLU
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 26, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 5, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 14, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 5, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Recipharm Leganes SLU
- FDA Inspection 1261202 - 2023-10-26
- FDA Inspection 1091302 - 2017-10-05
- FDA Inspection 992010 - 2016-10-14
- FDA Inspection 651878 - 2010-02-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.